LLY Eli Lilly and Company

Price (delayed)

$150.63

Market cap

$144.07B

P/E Ratio

24.33

Dividend/share

$2.77

EPS

$6.19

Enterprise value

$158.04B

Sector: Healthcare
Industry: Drug Manufacturers - General
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Highlights

The equity has increased by 47% year-on-year and by 33% since the previous quarter
The quick ratio has increased by 6% since the previous quarter
The P/E is 43% below the 5-year quarterly average of 42.7 but 25% above the last 4 quarters average of 19.4
The EPS has decreased by 23% YoY but it has increased by 2% QoQ
The net income has contracted by 28% YoY

Key stats

What are the main financial stats of LLY
Market
Shares outstanding
956.47M
Market cap
$144.07B
Enterprise value
$158.04B
Valuations
Price to earnings (P/E)
24.33
Price to book (P/B)
35.2
Price to sales (P/S)
5.95
EV/EBIT
24.72
EV/EBITDA
20.74
EV/Sales
6.89
Earnings
Revenue
$22.95B
EBIT
$6.39B
EBITDA
$7.62B
Free cash flow
$5.22B
Per share
EPS
$6.19
Free cash flow per share
$5.76
Book value per share
$4.28
Revenue per share
$25.3
TBVPS
$33.65
Balance sheet
Total assets
$41.97B
Total liabilities
$37.7B
Debt
$16.33B
Equity
$4.09B
Working capital
$2.59B
Liquidity
Debt to equity
3.99
Current ratio
1.22
Quick ratio
0.68
Net debt/EBITDA
1.83
Margins
EBITDA margin
33.2%
Gross margin
78.7%
Net margin
24.5%
Operating margin
27.9%
Efficiency
Return on assets
14%
Return on equity
170.7%
Return on invested capital
20.3%
Return on capital employed
21.3%
Return on sales
27.9%
Dividend
Dividend yield
1.84%
DPS
$2.77
Payout ratio
44.7%

LLY stock price

How has the ELI LILLY stock price performed over time

Financial performance

How have ELI LILLY's revenue and profit performed over time
Revenue
$22.95B
Gross profit
$18.06B
Operating income
$6.39B
Net income
$5.62B
Gross margin
78.7%
Net margin
24.5%
LLY's operating income is up by 43% year-on-year and by 2.9% since the previous quarter
ELI LILLY's operating margin has increased by 35% YoY and by 3.7% from the previous quarter
ELI LILLY's net margin has decreased by 32% YoY but it has increased by 2.1% from the previous quarter
The net income has contracted by 28% YoY

Valuation

What is ELI LILLY stock price valuation
P/E
24.33
P/B
35.2
P/S
5.95
EV/EBIT
24.72
EV/EBITDA
20.74
EV/Sales
6.89
The P/E is 43% below the 5-year quarterly average of 42.7 but 25% above the last 4 quarters average of 19.4
The EPS has decreased by 23% YoY but it has increased by 2% QoQ
LLY's P/B is 100% above its 5-year quarterly average of 17.6 but 13% below its last 4 quarters average of 40.4
The equity has increased by 47% year-on-year and by 33% since the previous quarter
The stock's price to sales (P/S) is 27% more than its 5-year quarterly average of 4.7 and 8% more than its last 4 quarters average of 5.5
ELI LILLY's revenue has increased by 6% YoY

Efficiency

How efficient is ELI LILLY business performance
The company's return on equity has surged by 53% YoY but it fell by 9% QoQ
The ROS has decreased by 26% YoY but it has increased by 3.7% QoQ
The ROA has contracted by 26% YoY
The ROIC has contracted by 24% YoY

Dividends

What is LLY's dividend history
DPS
$2.77
Dividend yield
1.84%
Payout ratio
44.7%
Recent dividends

Financial health

How did ELI LILLY financials performed over time
LLY's total assets is 11% greater than its total liabilities
ELI LILLY's current ratio has increased by 10% from the previous quarter and by 8% YoY
LLY's total assets is up by 9% year-on-year and by 2.1% since the previous quarter
The equity has increased by 47% year-on-year and by 33% since the previous quarter
The company's debt to equity fell by 32% YoY and by 29% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.